Cargando…
Clinical Allogeneic and Autologous Islet Cell Transplantation: Update
Islet cell transplantation is categorized as a β-cell replacement therapy for diabetic patients who lack the ability to secrete insulin. Allogeneic islet cell transplantation is for the treatment of type 1 diabetes, and autologous islet cell transplantation is for the prevention of surgical diabetes...
Autor principal: | Matsumoto, Shinichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138095/ https://www.ncbi.nlm.nih.gov/pubmed/21785738 http://dx.doi.org/10.4093/dmj.2011.35.3.199 |
Ejemplares similares
-
Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation
por: Nayak, Deepak Kumar, et al.
Publicado: (2016) -
The Current Status of Allogenic Islet Cell Transplantation
por: Czarnecka, Zofia, et al.
Publicado: (2023) -
A comparison of the inflammatory response following autologous compared with allogenic islet cell transplantation
por: Chung, Wen Yuan, et al.
Publicado: (2021) -
Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update
por: Bilgin, Yavuz M
Publicado: (2021) -
Autoimmunity in Autologous Islet Transplantation
por: Ali, Khawla F., et al.
Publicado: (2018)